Cannabis Campaigners' Guide News Database result:


After you have finished reading this article you can click here to go back.

UK: GW Pharma submits cannabis-based drug

Reuters

Monday 31 Mar 2003

---
LONDON, March 31 (Reuters) - Marijuana-based drugs firm GW Pharmaceuticals
Plc said on Monday it had submitted its first cannabis-based prescription
medicine for approval by Britain's industry regulator, the Medicines
Control Agency.

A spokesman said the firm was still in talks with prospective marketing
partners for the drug, which is sprayed into the mouth rather than smoked
and aims to give pain relief for multiple sclerosis patients.

A partner would be named during the first half of this year and UK approval
of the drug was likely by the end of the year, in line with previous
guidance, the spokesman said.

GW, which cultivates some 40,000 marijuana plants a year at a secret
location in the English countryside, holds the sole British licence to
develop medicines from cannabis, a widely-used but illegal drug.

 

 

 

After you have finished reading this article you can click here to go back. 




This page was created by the Cannabis Campaigners' Guide.

Feel free to link to this page!